New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic
Neuroendocrine prostate cancer (NEPC), an aggressive and highly malignant subtype of castration-resistant prostate cancer (CRPC), arises through drug resistance mechanisms involving genomic alterations, epigenetic remodeling, tumor microenvironment (TME) reprogramming, and lineage plasticity. A hall...
Saved in:
| Main Authors: | Maoping Cai, Fengtao Zheng, Yang-Zi Ren, Chuqian Zhen, Dujiang Fu, Xian-Lu Song, Qing Li, Yuanyuan Qu, Zhe-Sheng Chen, Shan-Chao Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Research |
| Online Access: | https://spj.science.org/doi/10.34133/research.0791 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer
by: Zoe R. Maylin, et al.
Published: (2024-12-01) -
Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01) -
Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway
by: Maoping Cai, et al.
Published: (2025-01-01) -
Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors
by: Xiong Zhang, et al.
Published: (2025-03-01) -
Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer
by: Weijie Zhang, et al.
Published: (2024-09-01)